Analysis of immunophenotypes and expressions of non-myeloid antigens in acute myeloid leukemia.
10.12122/j.issn.1673-4254.2020.11.16
- Author:
Weiwei WANG
1
;
Yuanhong XU
1
Author Information
1. Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
- Publication Type:Journal Article
- Keywords:
acute myeloid leukemia;
flow cytometry;
immunophenotypes;
non-myeloid differentiation antigens
- MeSH:
Cell Count;
Flow Cytometry;
Humans;
Immunophenotyping;
Leukemia, Myeloid, Acute;
Prognosis
- From:
Journal of Southern Medical University
2020;40(11):1639-1644
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the characteristics of immunophenotypes and expressions of non-myeloid differentiation antigens in acute myeloid leukemia (AML) and their value in diagnosis and prognostic evaluation of AML.
METHODS:We examined the immunophenotypes of 109 patients with AML using BD FACSCalibur flow cytometry and analyzed the association of the immunophenotypes and expressions of non-myeloid differentiation antigens with the prognosis and complete remission (CR) rate of the patients.
RESULTS:Immunophenotype analysis showed that the positivity rates of the myeloid differentiation antigens of AML cells decreased in the order of CD13, CD117, CD33, MPO and CD15; the positivity rates of CD117, CD13, CD33 and MPO did not differ significantly (
CONCLUSIONS:Immunophenotyping and analysis of non-myeloid differentiation antigens can be of great clinical significance for the diagnosis and prognostic evaluation of AML, and serve also as one of the important bases for the diagnosis and treatment of AML.
